Hyponatraemia: New associations and new treatments

European Journal of Endocrinology

Volumn 162, Issue SUPPL. 1, 2010, Pages

  Thompson, C J ^a  

^a BEAUMONT HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

TOLVAPTAN; VASOPRESSIN ANTAGONIST; BENZAZEPINE DERIVATIVE;

DISEASE ASSOCIATION; EDITORIAL; HEALTH CARE COST; HUMAN; HYPONATREMIA; MORBIDITY; MORTALITY; PRIORITY JOURNAL; CLINICAL TRIAL;

BENZAZEPINES; CLINICAL TRIALS AS TOPIC; HUMANS; HYPONATREMIA;

EID: 77953647400     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-10-0374     Document Type: Editorial

References (26)

1. Ellison DH & Berl T. Clinical practice. The syndrome of inappropriate antidiuresis. New England Journal of Medicine 2007 356 2064-2072.
2. Upadhyay A, Jaber BL & Madias NE. Incidence and prevalence of hyponatremia. American Journal of Medicine 2006 119 S30-S35.
3. Sherlock M, O'Sullivan E, Agha A, Behan LA, Owens D, Finucane F, Rawluk D, Tormey W & Thompson CJ. Incidence and pathophysiology of severe hyponatraemia in neurosurgical patients. Postgraduate Medical Journal 2009 85 171-175.
4. DeVita MV, Gardenswartz MH, Konecky A & Zabetakis PM. Incidence and etiology of hyponatremia in an intensive care unit. Clinical Nephrology 1990 34 163-166. (Pubitemid 20342876)
5. Miller M, Morley JE & Rubenstein LZ. Hyponatremia in a nursing home population. Journal of the American Geriatrics Society 1995 43 1410-1413.
6. Miller M. Hyponatremia and arginine vasopressin dysregulation: mechanisms, clinical consequences, and management. Journal of the American Geriatrics Society 2006 54 345-353.
7. Hawkins RC. Age and gender as risk factors for hyponatremia and hypernatremia. Clinica Chimica Acta 2003 337 169-172. (Pubitemid 37329815)
8. Huda MS, Boyd A, Skagen K, Wile D, van Heyningen C, Watson I, Wong S & Gill G. Investigation and management of severe hyponatraemia in a hospital setting. Postgraduate Medical Journal 2006 82 216-219.
9. Schwartz WB, Bennett W, Curelop S & Bartter FC. A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiuretic hormone. American Journal of Medicine 1957 23 529-542.
10. Anderson RJ, Chung HM, Kluge R & Schrier RW. Hyponatremia: a prospective analysis of its epidemiology and the pathogenetic role of vasopressin. Annals of Internal Medicine 1985 102 164-168. (Pubitemid 15157162)
11. Clayton JA, Le Jeune IR & Hall IP. Severe hyponatraemia in medical in-patients: aetiology, assessment and outcome. Quarterly Journal of Medicine 2006 99 505-511.
12. Sherlock M, O'Sullivan E, Agha A, Behan LA, Rawluk D, Brennan P, Tormey W & Thompson CJ. The incidence and pathophysiology of hyponatraemia after subarachnoid haemorrhage. Clinical Endocrinology 2006 64 250-254.
13. Arieff AI, Llach F & Massry SG. Neurological manifestations and morbidity of hyponatremia: correlation with brain water and electrolytes. Medicine 1976 55 121-129.
14. Renneboog B, Musch W, Vandemergel X, Manto MU & Decaux G. Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits. American Journal of Medicine 2006 119 71.e1-71.e8.
15. Gankam Kengne F, Andres C, Sattar L, Melot C & Decaux G. Mild hyponatremia and risk of fracture in the ambulatory elderly. Quarterly Journal of Medicine 2008 101 583-588. (Pubitemid 351912001)
16. Verbalis JG, Barsony J, Sugimura Y, Tian Y, Adams DJ, Carter EA & Resnick HE. Hyponatremia-induced osteoporosis. Journal of Bone and Mineral Research 2009 25 554-563.
17. Gill G, Huda B, Boyd A, Skagen K, Wile D, Watson I & van Heyningen C. Characteristics and mortality of severe hyponatraemia - a hospital-based study. Clinical Endocrinology 2006 65 246-249. (Pubitemid 44079690)
18. Terzian C, Frye EB & Piotrowski ZH. Admission hyponatremia in the elderly: factors influencing prognosis. Journal of General Internal Medicine 1994 9 89-91. (Pubitemid 24059127)
19. Klein L, O'Connor CM, Leimberger JD, Gattis-Stough W, Piña IL, Felker GM, Adams KF Jr, Califf RM, Gheorghiade M & OPTIME-CHF Investigators. Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) Study. Circulation 2005 111 2454-2460.
20. Zilberberg MD, Exuzides A, Spalding J, Foreman A, Jones AG, Colby C & Shorr AF. Hyponatremia and hospital outcomes among patients with pneumonia: a retrospective cohort study. BMC Pulmonary Medicine 2008 8 16.
21. Stelfox HT, Ahmed SB, Khandwala F, Zygun D, Shahpori R & Laupland K. The epidemiology of intensive care unit-acquired hyponatraemia and hypernatraemia in medical-surgical intensive care units. Critical Care 2008 12 R162.
22. Waikar SS, Mount DB & Curhan GC. Mortality after hospitalization with mild, moderate, and severe hyponatremia. American Journal of Medicine 2009 122 857-865.
23. Sajadieh A, Binici Z, Mouridsen MR, Nielsen OW, Hansen JF & Haugaard SB. Mild hyponatremia carries a poor prognosis in community subjects. American Journal of Medicine 2009 122 679-686.
24. Shea AM, Hammill BG, Curtis LH, Szczech LA & Schulman KA. Medical costs of abnormal serum sodium levels. Journal of the American Society of Nephrology 2008 19 764-770.
25. Hoorn EJ, Lindemans J & Zietse R. Acute and concomitant deterioration of hyponatremia and renal dysfunction associated with heart and liver failure. Clinical Nephrology 2006 65 248-255.
26. Schrier RW, Gross P, Gheorghiade M, Berl T, Verbalis JG, Czerwiec FS, Orlandi C & SALT Investigators. Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. New England Journal of Medicine 2006 355 2099-2112. (Pubitemid 44749318)